Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls
Xiaoyu Zhao(University of California San Diego), Juncheng Dai(Nanjing Medical University), Hongbing Shen(Nanjing Medical University), Hongxia Ma(Jiangsu Cancer Hospital), Adonina Tardón(Universidad de Oviedo), Penella J. Woll(University of Sheffield), Sanjay Shete(The University of Texas MD Anderson Cancer Center), Shanbeh Zienolddiny(National Institute of Occupational Health), Stephen Lam, Angeline S. Andrew(Dartmouth College), Melinda C. Aldrich(Vanderbilt University Medical Center), Alpa V. Patel(St. Elizabeth's Hospital), Neil E. Caporaso(Department of Health and Human Services), Demetrius Albanes(National Cancer Institute), Angela Risch(German Cancer Research Center), Christopher I. Amos(Dartmouth College), Susanne M. Arnold(University of Kentucky), Ivan P. Gorlov(Dartmouth College), Guangfu Jin(Wuhan Prevention and Treatment Center for Occupational Diseases), Mattias Johansson(Centre international de recherche sur le cancer), John K. Field(University of Liverpool), Lambertus A. Kiemeney(Oslo University Hospital), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Na Qin(Nanjing Medical University), Michael P.A. Davies(University of Liverpool), Matthew B. Schabath(Moffitt Cancer Center), Heike Bickeböller(Nephrologisches Zentrum Goettingen), Kjell Grankvist(Umeå University), Stig E. Bojesen(University of Copenhagen), Olga Y. Gorlova(Dartmouth College), Philip Lazarus(National Institutes of Health), Gad Rennert(Carmel Medical Center), Zhibin Hu(Nanjing Medical University), David C. Christiani(Harvard University), Mei Wang(Wuxi People's Hospital), Yifan Wang(Io Therapeutics (United States)), Geoffrey Liu(Princess Margaret Cancer Centre), Meng Zhu(Nanjing Medical University), Chu Chen(University of Washington), Yue Jiang(Nanjing Medical University), Jingyi Fan(Suzhou Municipal Hospital), Meiqi Yang(Nanjing Medical University), Mikael Johansson(Centre international de recherche sur le cancer), Maria Teresa Landi(National Cancer Institute), Gary E. Goodman(Fred Hutch Cancer Center), H.‐Erich Wichmann(Zimmer Biomet (Germany)), Paul Brennan(Centre International de Recherche sur le Cancer)
Cited by 8
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures
|Biostatistics|2014|1.8k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k